Market Research Logo

US Market for Pacemakers and Cardiac Resynchronization Therapy Devices - MedCore

The heart’s natural pacemaker is called the sinoatrial (SA) node and, in a healthy heart, the electrical pulse generated at the SA node travels to the atrioventricular (AV) node and down through the bundle of His (also known as the atrioventricular bundle) to the ventricles. Individuals who suffer from bradycardia, which is an abnormal heart rate below 60 beats per minute, have a defective SA node and require the assistance of an artificial pacemaker for healthy heart function. Bradycardia can also result from a blockage in the heart’s conduction pathway that ranges from partial to full inhibition of the electrical impulse. In either case, an artificial pacemaker is used for diagnosing cardiac arrhythmia and paces the heart as necessary. Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)

CRT-P devices are modified pacemakers that are capable of regulating the rhythm of both the left and right ventricles of the heart. This bi-ventricular pacing is necessary when heart contractions are out of sync, resulting in insufficient blood flow to the body. To regulate the rhythm of the left ventricle, CRT devices use a third lead, known as a left ventricle (LV) lead.

Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)

CRT-D devices are similar to CRT-P devices, but have the capabilities of an implantable defibrillator. CRT-D devices are very popular, partly because they have the capability to deal with most types of arrhythmias and can act as a defibrillator in case of a sudden cardiac event.

The primary disadvantages of cardiac resynchronization therapy devices are their high cost and shorter battery lifespan. This has limited the popularity of CRT-P devices, as they are far more expensive than equivalent pacemaker products.


EXECUTIVE SUMMARY FOR COMPLETE CARDIAC RHYTHM MANAGEMENT SUITE
1.1 U.S. CARDIAC RHYTHM MANAGEMENT MARKET
1.2 TREND ANALYSIS
1.3 PACEMAKER MARKET
1.4 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET
1.5 CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET
1.6 CARDIAC LEAD MARKET
1.7 COMPETITIVE ANALYSIS
1.8 LIST OF PROCEDURAL CODES
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PACEMAKER MARKET
3.1 INTRODUCTION
3.1.1 Single and Dual Chamber Devices
3.1.2 New Technologies
3.1.3 Initial Placement and Replacement of Pacemakers
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Total Pacemaker Market
3.3.2 Total Single-Chamber Pacemaker Market
3.3.2.1 Initial Placement Single-Chamber Pacemaker Market
3.3.2.2 Replacement Single-Chamber Pacemaker Market
3.3.3 Total Dual-Chamber Pacemaker Market
3.3.3.1 Initial Placement Dual-Chamber Pacemaker Market
3.3.3.2 Replacement Dual-Chamber Pacemaker Market
3.3.4 Leadless Pacemaker Market
3.4 PRICE ANALYSIS
3.5 DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET
4.1 INTRODUCTION
4.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
4.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total CRT Market
4.3.2 Total CRT-P Market
4.3.2.1 Initial Placement CRT-P Market
4.3.2.2 Replacement CRT-P Market
4.3.3 Total CRT-D Market
4.3.3.1 Initial Placement CRT-D Market
4.3.3.2 Replacement CRT-D Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Cardiac Rhythm Management Market, U.S., 2012 – 2022 1
Chart 1 2: Cardiac Rhythm Management Market Growth by Segment, U.S., 2012 – 2022 2
Chart 1 3: Pacemaker Market by Segment, U.S., 2015 & 2022 3
Chart 1 4: ICD Market by Segment, U.S., 2015 – 2018 4
Chart 1 5: Growth by Market Segment, U.S., 2015 – 2018 5
Chart 1 6: Cardiac Lead Market by Segment, U.S., 2015 – 2018 6
Chart 1 7: Leading Competitors, Cardiac Rhythm Management Market, U.S., 2015 7
Chart 3 1: Pacemaker Market by Segment, U.S., 2012 – 2022 25
Chart 3 2: Pacemaker Market Breakdown, U.S., 2015 26
Chart 3 3: Pacemaker Market Breakdown, U.S., 2022 26
Chart 3 4: Total Pacemaker Market, U.S., 2012 – 2022 28
Chart 3 5: Total Single-Chamber Pacemaker Market, U.S., 2012 – 2022 30
Chart 3 6: Initial Placement Single-Chamber Pacemaker Market, U.S., 2012 – 2022 31
Chart 3 7: Replacement Single-Chamber Pacemaker Market, U.S., 2012 – 2022 32
Chart 3 8: Total Dual-Chamber Pacemaker Market, U.S., 2012 – 2022 34
Chart 3 9: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2012 – 2022 35
Chart 3 10: Replacement Dual-Chamber Pacemaker Market, U.S., 2012 – 2022 36
Chart 3 11: Leadless Pacemaker Market, U.S., 2012 – 2022 38
Chart 3 12: Leading Competitors, Pacemaker Market, 2015 44
Chart 4 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2012 – 2022 47
Chart 4 2: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2015 48
Chart 4 3: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2022 48
Chart 4 4: Total CRT Market, U.S., 2012 – 2022 50
Chart 4 5: Total CRT-P Market, U.S., 2012 – 2022 52
Chart 4 6: Initial Placement CRT-P Market, U.S., 2012 – 2022 53
Chart 4 7: Replacement CRT-P Market, U.S., 2012 – 2022 54
Chart 4 8: Total CRT-D Market, U.S., 2012 – 2022 56
Chart 4 9: Initial Placement CRT-D Market, U.S., 2012 – 2022 57
Chart 4 10: Replacement CRT-D Market, U.S., 2012 – 2022 58
Chart 4 11: Leading Competitors, Cardiac Resynchronization Therapy Device Market, U.S., 2015 64
List of Figures
Figure 1 1: Procedural Codes, U.S., 2015 8
Figure 3 1: Pacemaker Market by Segment, U.S., 2012 – 2022 (US$M) 25
Figure 3 2: Total Pacemaker Market, U.S., 2012 – 2022 27
Figure 3 3: Total Single-Chamber Pacemaker Market, U.S., 2012 – 2022 30
Figure 3 4: Initial Placement Single-Chamber Pacemaker Market, U.S., 2012 – 2022 31
Figure 3 5: Replacement Single-Chamber Pacemaker Market, U.S., 2012 – 2022 32
Figure 3 6: Total Dual-Chamber Pacemaker Market, U.S., 2012 – 2022 34
Figure 3 7: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2012 – 2022 35
Figure 3 8: Replacement Dual-Chamber Pacemaker Market, U.S., 2012 – 2022 36
Figure 3 9: Leadless Pacemaker Market, U.S., 2012 – 2022 38
Figure 3 10: Pricing Tiers, Pacemaker Market, U.S., 2015 39
Figure 3 11: Drivers and Limiters, Pacemaker Market, U.S., 2015 41
Figure 3 12: Leading Competitors, Pacemaker Market, 2015 43
Figure 4 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2012 – 2022 (US$M)
Figure 4 2: Total CRT Market, U.S., 2012 – 2022 49
Figure 4 3: Total CRT-P Market, U.S., 2012 – 2022 52
Figure 4 4: Initial Placement CRT-P Market, U.S., 2012 – 2022 53
Figure 4 5: Replacement CRT-P Market, U.S., 2012 – 2022 54
Figure 4 6: Total CRT-D Market, U.S., 2012 – 2022 56
Figure 4 7: Initial Placement CRT-D Market, U.S., 2012 – 2022 57
Figure 4 8: Replacement CRT-D Market, U.S., 2012 – 2022 58
Figure 4 9: Drivers and Limiters, Cardiac Resynchronization Therapy Device Market, U.S., 2015 61
Figure 4 10: Leading Competitors, Cardiac Resynchronization Therapy Device Market, U.S., 2015 63

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report